Treatment of multi-organ bodily distress syndrome. A double-blinded placebo controlled trial of the effect of Imipramine (STreSS-3) Behandling af multi-organ bodily distress syndrome. Et dobbelt-blindet placebokontrolleret forsøg af effekten af Imipramin (STreSS-3)
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Understand this study
What did researchers investigate?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Compensation and expense reimbursement have not been verified for this summary.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 140
- Sponsor
- Per Klausen Fink
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Denmark
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2011-004294-87
- Official title
- Treatment of multi-organ bodily distress syndrome. A double-blinded placebo controlled trial of the effect of Imipramine (STreSS-3) Behandling af multi-organ bodily distress syndrome. Et dobbelt-blindet placebokontrolleret forsøg af effekten af Imipramin (STreSS-3)
Recruitment & locations
CompletedDenmark
Registry details
F 45 Somatisation disorder and related disorders. Bodily distress syndrome is a new diagnosis that resembles F 45 Somatisation disorder, but with a more specific set of diagnostic criteria. F 45 Somatiseringstilstand og lignende tilstande. Bodily distress syndrome er en ny diagnose, der ligner F 45 Somatiseringstilstand, men dog med mere specifikke diagnostiske kriterier.
- Denmark — Completed
Questions about this study
Who is behind this study?
The study sponsor is Per Klausen Fink.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me